The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range

Nicolaas D. Vlieland, Helga Gardarsdottir, Marcel L. Bouvy, Toine C. G. Egberts, Bart J. F. van den Bemt

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)704-709
JournalRheumatology
Volume55
Issue number4
DOIs
Publication statusPublished - Apr 2016

Keywords

  • biologic DMARDs
  • rheumatoid arthritis
  • anti-TNF
  • epidemiology

Cite this